Last updated on February 2018

Acromegaly - Before and After Treatment


Brief description of study

The aim of the study is to investigate sleep apnea, circulation and metabolism in acromegaly before and after surgery and/or medical treatment.

Detailed Study Description

Acromegaly is a rare disease caused by a growth hormone (GH) producing pituitary adenoma. Surgery is primary treatment, whereas medical treatment with a somatostatin analogue (SA), which suppresses GH secretion and reduces tumour size, is used when surgery is insufficient or unfeasible. Acromegaly is associated with metabolic abnormalities which contributes to an increased morbidity and mortality if left untreated. To which extend these abnormalities reverses after treatment, and if treatment modality influences the outcome, remain elusive. The aim of the study is to investigate sleep apnea, circulation and metabolism in acromegaly before and after surgery and/or medical treatment

Clinical Study Identifier: NCT03431727

Contact Investigators or Research Sites near you

Start Over

Jens Otto L Jørgensen, Professor

Aarhus University Hospital, Department of internal medicine and endocrinologi
Aarhus, Denmark
  Connect »